ArticleAMIA ... Annual Symposium proceedings. AMIA Symposium2022
Development of a Patient Decision Aid for Refractive Eye Surgery.
Article in AMIA ... Annual Symposium proceedings. AMIA Symposium, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Development of a web-based patient decision aid for myopia laser correction method.BMC medical informatics and decision making · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
To address the needs of patient decision aid for refractive eye surgery, we developed a web-based tool, EyeChoose, which provides patient education, assists in selection of a specific surgical modality, generates customized recommendations, and links patients to local surgeons, targeting specifically the population of college students. We conducted a focus group interview for needs assessment. We designed a scoring algorithm to provide customized recommendation of surgical modalities based on a patient's medical history and personal preferences. We completed a prototype implementation of the tool. Initial data from a validation study indicated that the system achieved 99.18% accuracy in its recommendation. A study to examine the usefulness and usability of EyeChoose is ongoing. Future research is required to implement the tool in naturalistic settings and to examine the generalizability of the findings to other populations.
Indexed as
Identifiers
37128460PMC10148291What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.